Following news of a planned CEO departure for the United States’ top drug industry lobbying group, the Pharmaceutical ...

In Milan this week, Novo and Eli Lilly took the stage at the European Association for the Study of Diabetes 2026 meeting with ...

In addition, medical countermeasures and animal health products also qualify for 0% import duties. Drugs belonging to those ...

Inizio Evoke has unveiled a trio of appointments, installing leaders across its media, artificial intelligence and client ...

Ronald Reagan was in the White House, Michael Jackson’s “Thriller” was pumping through Walkmans everywhere, and biotech was ...

William Shatner has partnered with Audien Hearing to “Boldly Hear What’s Next.” The alliance makes the “Star Trek” actor the ...

INS is Gazyva’s second immune-mediated indication, following an approval last October in adult lupus nephritis, a potentially ...

Although a clinical setback last year continues to loom in the background, AbbVie’s $8.7 billion bet on Cerevel Therapeutics ...

BioNTech is set to shutter multiple sites in Germany, impacting about 1,800 jobs, after efforts to find buyers fell through.

Eli Lilly’s portfolio of weight loss and diabetes medications have become a dominant force in the market—but access to the ...

The commercial environment facing today's life sciences sales teams looks very different from the one many organizations were ...

Bristol Myers Squibb plans another major round of job cuts in New Jersey, bringing the number of total layoffs the company ...